Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Lansdowne Partners Adds to Position in Tableau Software

Paul Ruddock & Steve Heinz‘s London-based fund Lansdowne Partners disclosed, in a new filing with the SEC, surging its position in Tableau Software Inc (NYSE:DATA) to 575,000 class A shares, from 375,000 reported in its latest 13F. The stake now amasses 6.10% of the company’s class A common stock.

Tableau Software

Tableau shares are currently trading at a price of $63.68 and have a beta of -3.96. During the 3rd quarter of 2013, the company registered a 65% increase in revenue and reported sales of 33.5 million. Tableau has, however, reported a loss of 0.05 per diluted share. The company does not pay dividends.

At the recent Amazon Web Services (AWS) re:Invent conference, on November 14th,  Tableau Software announced an expansion in the companies business relations with Amazon. Dan Jewett, Tableau Software’s Vice President of Product Management said:

 We are thrilled to extend our work with AWS and support the growing demand to see and understand data. AWS’ rich suite of offerings combined with Tableau provides our joint customers, like Foursquare, Sling Media, and Zillow with more supported options for accessing and analyzing their data in low cost model compared to traditional business intelligence platforms.

On November 7th, Tableau announced that 7.7 million Class A shares would be sold at a price of $65.00. All shares are to be sold by current stock holders, the company not receiving any proceeds from the sale.

Disclosure: none

Recommended reading:

Coghill Capital Sells Some Autobytel Shares

Wexford Capital Cuts Its Diamondback Energy Position

Kyle Bass’ Hayman Advisors Discloses Position in Post-IPO NMI Holdings


Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!